An individual who has kidney cancer and who is unable to undergo a surgical procedure to remove their malignancy may need to have cryoablation as part of their treatment. Numerous health ...

IceCure Medical ICCM presented interim results from its ICESECRET kidney cancer cryoablation study at the European Association of Urology Conference in Spain. The study reported an 88.7% ...

Halton Healthcare is the first regional hospital to offer renal (kidney) cryoablation, a minimally invasive procedure that targets kidney tumours with precision while minimizing recovery time.

ICCM reports strong kidney cancer cryoablation study results, showcasing 88.7% recurrence-free rates and reinforcing its position in cryoablation technology. IceCure Medical Ltd. (Nasdaq ...

Cryoablation of Breast Cancer: The Challenge of an Innovative ... destruction in benign and cancerous lesions, including breast, kidney, lung, and liver. ProSense® enhances patient and provider ...

About IceCure Medical IceCure Medical (Nasdaq: ICCM) develops and markets advanced liquid-nitrogen-based cryoablation ... areas being breast, kidney, bone and lung cancer. Its minimally invasive ...

"Given the novelty of our product and the importance of breast cancer in public health, the FDA has included many stakeholders in the discussion of the De Novo marketing clearance for ProSense ...